Abstract:Objective To investigate the effect of N-(3, 4-dimethoxycinnamonyl) anthranilic acid (3, 4-DAA) in mice skin transplantation and explore the mechanisms. Methods In vitro experiments, T lymphocytes monoplast suspension was isolated from BALB/C mice splenocytes on day 7 after allogene mice skin transplantation. Half of the suspension was used to measure the splenic T lymphocyte proliferation inhibition rate using methyl thiazolyl tetrazolium (MTT) measurement. The other half of suspension was divided into 3 groups: c1 group (added RPMI 1640 solution 10 μl), c2 group (added 3, 4-DAA 100 μmol/L) and c3 group (added 3, 4-DAA 200 μmol/L). All the samples were cultured for 72 h before pathematology examination. Western blot was also applied to analyze the expression of indoleamine 2, 3-dioxygenase (IDO). High performance liquid chromatography (HPLC) was used to determine the IDO activity. In vivo experiment, different concentrations of 3, 4-DAA were used as drug interposition and sometimes combined with sirolimus. The skin grafts were collected for pathematology examination on day 10 after transplantation. The expression of IDO in the splenic T lymphocytes monoplast suspension was measured by Western blot. And the IDO activity in the serum of transplanted mice was measured by HPLC. Results In vitro experiments, the MTT results showed that 3, 4-DAA significantly decreased the T lymphocyte proliferation and had significant dosage effect (P＜0.05-P＜0.01). Under the inverted microscope, the lymphocyte proliferation was significantly restrained in the splenic T lymphocytes monoplast suspension of skin transplanted mice in c3 and c2 group, compared with c1 group. And the restraint was more significant in c3 group compared with c2 group, which showed that 3, 4-DAA could restrain the lymphocyte proliferation in the spleen. In vivo experiment, the immunologic injury condition of skin graft significantly relieved in the 3, 4-DAA treated group. Both in vitro and in vivo experiments showed that IDO expression and IDO activity significantly increased in 3, 4-DAA treated group compared with the control group (P＜0.05-P＜0.01). Conclusion 3, 4-DAA can suppress the rejection of mice skin transplantation and relieve the damage of allograft rejection through enhancing the IDO activity.

[Effect of Anisomycin on Allogeneic Skin Transplantation in Mice].

Effects of Anisomycin on the reactivity and cytotoxicity of Tlymphocytes in mice

Anisomycin inhibits the behaviors of T cells and the allogeneic skin transplantation in mice.

Establishment of an Allogenetic Skin Transplant Model in Mice for Evaluating Immunosuppressive Drugs

Study on variation characteristics of anti-donor specific antibodies in different species of sensitized mice after skin transplantation

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Establishment of an allogenetic skin transplantation model in mice

Study on Effect and Mechanism of N-(3,4-dimethoxycinnamonyl)anthranilic Acid Mediated Negative Immune Regulation in Mice Skin Transplantation

Inhibition of MD-1 Expression by Immunosuppressants or Antisense Oligodeoxynucleotides on Skin Allograft Survival in Mice

Experimental research of matrine on anti-rejection effect after skin transplantation

Immunosuppressive effects of ginsenoside-Rd on skin allograft rejection in rats.

MD-1 expression and its effects on skin allograft under immunosuppressive condition in mice

Inhibition of MD-1 Expression by Antisense Oligodeoxynucleotides and Its Impact on Skin Allograft Survival of Mouse

Induction of Immunotolerance in Mice after Skin Allotransplantation by Subcutaneous Injection of Bone Marrow

Study on the suppressive effects of CMS030 tetramer on allograft rejection in mice

Immunosuppressive effects of emodin on skin transplantation in mice

Amplification of Memory T Cells in Mice by Rejection after Skin Transplantation

In vivo toxicological evaluation of Anisomycin.

Control of allograft rejection in mice by applying a novel neuropeptide, cortistatin

Allograft survival enhancement using doxycycline in alkali-burned mouse corneas.

Peptide Nucleic Acid Antisense Prolongs Skin Allograft Survival by Means of Blockade of CXCR3 Expression Directing T Cells into Graft.